21Shares Solana Staking ETF (TSOL): Entry into a Material Definitive Agreement

21Shares Solana Staking ETF (TSOL) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry into a Material Definitive Agreement. Benchmark Licensing Agreement On August 20, 2026, 21Shares US LLC (the “Sponsor”) entered into a licensing agreement (the “Benchmark Licensing Agreement”) with FTSE International Limited (“FTSE” or the “Benchmark Provider”). E

Event · Contract
Role
customer
Counterparty
FTSE International Limited
Duration
one-year initial term
Scope
FTSE Solana Index

Facts are quoted from the filing text and checked against it.

Original reporting
Published Aug 26, 2026, 8:14 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 26, 2026, 8:14 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefCorporate actions
Primary signal
$TSOL
Neutral
high confidence
Mentioned
$TSOL
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$TSOLNeutralLow
01

Why it matters

The filing signals a shift in the ETF's pricing benchmark, which may affect NAV stability and investor confidence. No immediate cash impact, but the quarterly fee payment in SOL could affect liquidity.

02

Market read

Primary disclosure of a material definitive agreement for a listed crypto ETF; modest trading relevance.

03

What to watch

Potential impact of the quarterly sponsor fee payment in SOL on cash flow and tax considerations for shareholders.

Relevance 6/10Novelty 6/10Timing: filed Aug 26 2026

Background

21Shares Solana Staking ETF (TSOL) previously used the CME CF Solana‑Dollar Reference Rate. The new agreement replaces it with the FTSE Solana Index and adjusts sponsor fee timing.

Company-level read

Ticker impact

$TSOLNeutralHigh confidence
Context

SEC 8‑K reports 21Shares Solana Staking ETF entering a Benchmark Licensing Agreement and amending sponsor fee terms.

Expected impact

Modest price movement expected as investors adjust to the new benchmark and fee schedule.

Evidence & confidence

The filing is the first public disclosure of the agreement; the change is material to the ETF's valuation methodology but does not involve large capital flows.

Market effects

May influence other crypto‑linked ETFs that use similar benchmarks.

Limited to U.S. listed crypto ETF market.

Minimal; primarily affects investors in the Solana staking ETF.

Counterpoint

The benchmark change could be seen as a risk if FTSE's methodology diverges from CME's established reference rate.

Key entities

  • 21Shares US LLC

    Sponsor of the TSOL ETF, entering the new licensing agreement.

  • FTSE International Limited

    Provider of the FTSE Solana Index used as the new pricing benchmark.

Related articles

$CLPTMed

ClearPoint Neuro Raises ATM Offering Capacity to $150 Million With Stifel

ClearPoint Neuro (CLPT) increased its ATM offering capacity to $150M from $50M via an amended agreement with Stifel. The company can sell shares through Stifel, with $27.5M available under the current prospectus. Additional sales require a new supplement. CLPT controls timing, price, and size of sales, paying up to 3% in commissions. The amendment was signed and effective on Nov 18, 2026.

$ASTSMed

AST SpaceMobile Sinks 8% as New Offering Filing Revives Dilution Fears

AST SpaceMobile (ASTS) fell 8% after filing for a new securities sale, raising dilution concerns. The company's share count rose from 200M to 300M between late 2024 and Q3 2026. AT&T (T) and Vodafone (VOD), which have stakes in AST, are also affected. AST's free cash flow was negative $1.8B over the last four quarters, with analysts expecting negative free cash flow through 2028.